AGE Research Group, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, NE4 5PL, UK.
NIHR Newcastle Biomedical Research Centre, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust and Newcastle University, Newcastle upon Tyne, UK.
Eur Geriatr Med. 2024 Jun;15(3):853-860. doi: 10.1007/s41999-024-00953-8. Epub 2024 Mar 6.
Greater transparency and consistency when defining multimorbidity in different settings is needed. We aimed to: (1) adapt published principles that can guide the selection of long-term conditions for inclusion in research studies of multimorbidity in hospitals; (2) apply these principles and identify a list of long-term conditions; (3) operationalise this list by mapping it to International Classification of Diseases 10th revision (ICD-10) codes.
Review by independent assessors and ratification by an interdisciplinary programme management group.
Agreement was reached that when defining multimorbidity in hospitals for research purposes all conditions must meet the following four criteria: (1) medical diagnosis; (2) typically present for ≥ 12 months; (3) at least one of currently active; permanent in effect; requiring current treatment, care or therapy; requiring surveillance; remitting-relapsing and requiring ongoing treatment or care, and; (4) lead to at least one of: significantly increased risk of death; significantly reduced quality of life; frailty or physical disability; significantly worsened mental health; significantly increased treatment burden (indicated by an increased risk of hospital admission or increased length of hospital stay). Application of these principles to two existing lists of conditions led to the selection of 60 conditions that can be used when defining multimorbidity for research focused on hospitalised patients. ICD-10 codes were identified for each of these conditions to ensure consistency in their operationalisation.
This work contributes to achieving the goal of greater transparency and consistency in the approach to the study of multimorbidity, with a specific focus on the UK hospital setting.
在不同环境下定义多病共存时,需要提高透明度和一致性。我们旨在:(1) 采用已发表的原则来指导选择纳入多病共存医院研究的长期疾病;(2) 应用这些原则并确定一组长期疾病;(3) 通过将其映射到国际疾病分类第 10 版 (ICD-10) 代码来实现该列表的操作化。
由独立评估人员进行审查,并由跨学科项目管理小组批准。
达成共识,即当出于研究目的在医院定义多病共存时,所有条件必须符合以下四个标准:(1) 医学诊断;(2) 通常持续至少 12 个月;(3) 至少有一种目前处于活跃状态;永久生效;需要当前治疗、护理或治疗;需要监测;缓解-复发,需要持续治疗或护理;(4) 导致至少以下之一:显著增加死亡风险;显著降低生活质量;虚弱或身体残疾;显著恶化心理健康;显著增加治疗负担(表现为住院风险增加或住院时间延长)。将这些原则应用于现有的两个疾病列表,选择了 60 种可用于定义以住院患者为重点的研究中的多病共存的条件。为这些疾病中的每一种确定了 ICD-10 代码,以确保其操作的一致性。
这项工作有助于实现提高多病共存研究方法透明度和一致性的目标,特别是在英国医院环境中。